Aemetis (AMTX) Misses Q1 EPS by 5c

Aemetis (NASDAQ: AMTX) reported Q1 EPS of ($0.33), $0.05 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $54.6 million versus the consensus estimate of $69.4 million.

For earnings history and earnings-related data on Aemetis (AMTX) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Alibaba (BABA) Misses Q2 EPS by 220c
• Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Letter of Intent with Darmiyan, Inc. to Explore Use of FDA De Novo Authorized BrainSee(R) AI Platform in Early Alzheimer's Disease